Pursuant to Regulation 30 & 33 of the SEBI (LODR) Regulations, 2015, we hereby inform you that the Board of Directors of Nutraplus India Limited (the Company) at it''s meeting held today, ....
Awaiting price reaction for this filing.
Nutraplus India's Board approved its Q1 FY26 standalone results showing negligible revenue of just Rs 0.36 lakh, essentially flat versus the same quarter last year, with a net loss of Rs 0.66 lakh (vs Rs 0.39 lakh loss in Q1 FY25), meaning losses widened. For the full FY25 (audited), the company reported total income of Rs 5.01 lakh and a net loss of Rs 5.01 lakh. The statutory auditor (Raman S. Shah & Associates) issued a Qualified Limited Review Report, citing non-compliance with listing timelines and the company's failure to provide financial data on time. The auditor also flagged an Emphasis of Matter noting that the company lost all its property, plant and equipment under the SARFAESI Act, 2002 after being declared a Non-Performing Asset in FY2020, with COVID-19 further delaying the auction process.
This is a deeply negative filing for shareholders — the company appears to be a near non-operational shell with virtually no revenue, continuing losses, loss of all physical assets to banks, and qualified auditor remarks. Investors should treat this stock with extreme caution as the going concern of the business is in serious doubt.